Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation, HomologousTransplantation ConditioningGranulocyte Colony-Stimulating FactorLeukapheresisMelphalanAntigens, CD34Blood Component RemovalHematologic NeoplasmsCombined Modality TherapyBone Marrow TransplantationCyclophosphamideStem Cell TransplantationHematopoietic Stem CellsMultiple MyelomaGraft vs Host DiseaseAntineoplastic Combined Chemotherapy ProtocolsBusulfanMyeloablative AgonistsGraft SurvivalTreatment OutcomeStem CellsLymphoma, Non-HodgkinBone MarrowEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceHematopoiesisBone Marrow CellsCarmustineIfosfamideCord Blood Stem Cell TransplantationCytophagocytosisSalvage TherapyVincristineTransplantation ChimeraTissue DonorsCytarabineAmyloidosisDisease-Free SurvivalHodgkin DiseaseWhole-Body IrradiationRetrospective StudiesBlood CellsNeoplasmsBlood Cell CountSurvival RateTime FactorsHistocompatibilityInfectionPlatelet CountSurvival AnalysisBone Marrow PurgingPOEMS SyndromeHistocompatibility TestingDoxorubicinImmunosuppressive AgentsLeukemiaLeukemia, Myeloid, AcuteLymphoma, T-CellTransplantation, IsogeneicRecombinant ProteinsVidarabineLeukocytes, MononuclearCarboplatinPrednisoneBone Marrow DiseasesLymphomaDexamethasoneImmunophenotypingFollow-Up StudiesAnemia, AplasticCytomegalovirus InfectionsFeasibility StudiesAntineoplastic AgentsProspective StudiesFlow CytometryT-LymphocytesGraft vs Leukemia EffectFatal OutcomeMyelodysplastic SyndromesCell SeparationBlood DonorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionCells, CulturedLeukocyte CountHematologic DiseasesAntigens, CDHistiocytosis, Non-Langerhans-CellImmunomagnetic SeparationCell DifferentiationPrecursor Cell Lymphoblastic Leukemia-LymphomaEmbryonic Stem CellsBone and Bones